DNA methylation is known to regulate CADM1 in various tumors, such as ATLL [93], cervical cancer [94,95,96,97], epithelial ovarian cancer [98], oral squamous cell carcinoma [99], and breast cancer [100], and this epigenetic modification-targeted treatment exhibits therapeutic potential against malignancy [93]. This evidence concerns the gene CADM1 and breast carcinoma.